Semaglutide Has an FDA Indication for MASH Wegovy received FDA accelerated approval for MASH (metabolic dysfunction-associated steatohepatitis) in August 2025
For weight management in the UK, medications like Wegovy are typically prescribed through specialist services for a maximum of 2 years (NICE TA875), while for diabetes management, GLP-1 RAs may be used long-term according to NICE guidance (NG28)
Timing depends on your insurance company, pharmacy benefit manager, and whether prior authorization is required
Tesamorelin is a synthetic form of growth-hormone-releasing hormone (GHRH), which participates in a wide range of physiological pathways, including the stimulation of the growth hormone secretion from the pituitary gland
Does altRx require insurance
If adherence and lifestyle factors are optimised, your clinician may consider dose escalation